14. Renal denervation

Ultrasound renal denervation vs sham

RADIANCE-HTN SOLO: 3 years
Objective
to assess the 3-year durability of office BP after stepwise antihypertension medication (AHM) followed by ultrasound renal denervation (RDN) or sham procedure
Study
multicentre, blinded, sham-controlled randomised trial
Population
patients with BP>135/85mm Hg after AHM for 2 to 5 months
Endpoints
change of office BP (OBP) (i.e off antihypertensive medication) from baseline to 36 months
Conclusion
ultrasound renal denervation was associated with a durable office blood pressure reduction up to 36 months. No sham data were provided
Rader et al. EuroIntervention. 2022;D-00305
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved